IBERE PHARMACEUTICALS (IBERU)
Institutional ownership reported to the SEC as of Q4 2022, across 8 quarters.
8
Reporting holders
$3.4M
Reported value
0.0%
Held as options
-5
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Schechter Investment Advisors, LLC | $1.8M | 175,562 | 0.16% | 5q | -0.9%-$16.0K |
| JANE STREET GROUP, LLC | $573.0K | 57,472 | 0.00% | 8q | -16.9%-$116.7K |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $365.7K | 36,568 | 0.05% | 8q | HELD |
| Terrapin Asset Management, LLC | $186.0K | 18,510 | 0.19% | new | FIRST |
| Wealthspring Capital LLC | $179.9K | 18,040 | 0.27% | 8q | -90.8%-$1.8M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $158.5K | 15,899 | 0.00% | 8q | -10.2%-$17.9K |
| Sage Mountain Advisors LLC | $131.6K | 13,200 | 0.03% | 8q | -5.8%-$8.2K |
| UBS Group AG | $6.0K | 600 | 0.00% | 5q | HELD |
| HRT FINANCIAL LP | $649 | 64,980 | 0.01% | 8q | HELD |
| GLAZER CAPITAL, LLC | $10 | 1,000 | 0.00% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2022 | 8 | $3.4M | 335,851 | 0 | 0 | 5 | 0.0% |
| Q3 2022 | 13 | $6.1M | 617,629 | 0 | 3 | 5 | 0.0% |
| Q2 2022 | 18 | $29.5M | 3,001,705 | 1 | 3 | 5 | 0.0% |
| Q1 2022 | 18 | $17.7M | 1,800,202 | 2 | 1 | 5 | 0.0% |
| Q4 2021 | 22 | $40.5M | 4,045,921 | 1 | 2 | 5 | 0.0% |
| Q3 2021 | 27 | $50.8M | 5,082,136 | 0 | 2 | 4 | 0.0% |
| Q2 2021 | 34 | $61.7M | 6,138,933 | 0 | 4 | 7 | 0.0% |
| Q1 2021 | 60 | $121.3M | 12,297,035 | 59 | 0 | 0 | 0.0% |